Taking these results together, we propose that the inhibition of GPR55 confers significant neuroprotective effects following ischemia, and treatment with GPR55 antagonist(s) could represent a significant novel strategy for stroke treatments, whether administered independently or in combination with other therapeutic approaches. The gene discussed is GPR55; the disease is stroke disorder.